[1]
Liza Baca, E. y Díaz Ferrer, J. 2018. HAP score as prognostic factor of hepatocellular carcinoma treated with transarterial chemoembolization in a Latin American center. Revista de Gastroenterología del Perú. 38, 2 (ago. 2018), 164–8. DOI:https://doi.org/10.47892/rgp.2018.382.893.